Pain Research and Management / 2019 / Article / Tab 6

Research Article

A Prospective Six-Month Study of Chronic Pain Sufferers: A Novel OTC Neuromodulation Therapy

Table 6

Average outcome measures for the different levels of final pain.

Last reported VAS% study sample (N = 240)7-day VAS (after 7-day treatment)Δ VAS (baseline: last reported)Δ QoL (baseline: last reported)Δ sleep (baseline: last reported)Δ medications (baseline: last reported)Δ physical activity (baseline: last reported)% stopped medication use% stopped nondrug pain therapies

0–118%1.437.41+5.48+2.22+3.02+2.183423
2–339%2.715.54+5.07+1.99+2.5+1.8616.517
4–528%3.593.91+4.6+1.76+2.02+1.413.514
6–712%4.312.58+3.95+1.23+0.57+0.98013
8–103%5.00−0.33+3.50+1.00+0.50+0.8300

Numerical values for the change measures can be found in Table 1.

You are browsing a BETA version of Hindawi.com. Click here to switch back to the original design.